PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Böhm, Michael
TI  - ONTARGET: Treatment Nonadherence Rapidly Increases CV Event Risk
DP  - 2011 Nov 01
TA  - MD Conference Express
PG  - 26--26
VI  - 11
IP  - 10
4099  - http://mdc.sagepub.com/content/11/10/26.short
4100  - http://mdc.sagepub.com/content/11/10/26.full
AB  - Patients who are at high risk for cardiovascular events face a vicious cycle in which treatment nonadherence increases event rates while events themselves reinforce nonadherence, according to new findings from the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET].